Terms: = Lymphoma AND DNMT3A, Q9Y6K1, 1788, ENSG00000119772, DNMT3A2, M_HsaIIIA AND Diagnosis
41 results:
1. [Mutation characteristics of angioimmunoblastic T-cell lymphoma: an analysis of 75 cases].
Shen X; Yi HM; Li AQ; Ouyang BS; Dong L; Wang CF
Zhonghua Bing Li Xue Za Zhi; 2024 Jan; 53(1):29-33. PubMed ID: 38178743
[No Abstract] [Full Text] [Related]
2. Clinical and histological study of follicular helper T-cell lymphomas with indolent evolution.
Messéant O; Drieux F; Sako N; Fataccioli V; Camus V; Robe C; Houot R; Tas P; Llamas-Gutierrez F; Lamaison C; Abraham J; Delage-Corre M; Benguerfi S; Bossard JB; Gaulard P; Lemonnier F
Eur J Cancer; 2024 Jan; 197():113479. PubMed ID: 38128263
[TBL] [Abstract] [Full Text] [Related]
3. Prognostic significance of persisting dnmt3a, ASXL1, and TET2 mutation burden in acute myeloid leukemia patients with allogeneic hematopoietic stem cell transplantation during complete remission.
Lai X; Xiao J; Wang T; Hou C; Chen J; Wu D; Xu Y
Leuk Lymphoma; 2024 Mar; 65(3):363-371. PubMed ID: 37990829
[TBL] [Abstract] [Full Text] [Related]
4. [Analysis of clinicopathological and molecular abnormalities of angioimmunoblastic T-cell lymphoma].
Shi YF; Wang HJ; Liu WP; Mi L; Long MP; Liu YF; Lai YM; Zhou LX; Diao XT; Li XH
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Jun; 55(3):521-529. PubMed ID: 37291929
[TBL] [Abstract] [Full Text] [Related]
5. Clinicopathologic Features of Therapy-Related Myeloid Neoplasms in Patients with Myeloma in the Era of Novel Therapies.
Jelloul FZ; Quesada AE; Yang RK; Li S; Wang W; Xu J; Tang G; Yin CC; Fang H; El Hussein S; Khoury J; Bassett RL; Garcia-Manero G; Manasanch EE; Orlowski RZ; Qazilbash MH; Patel KP; Medeiros LJ; Lin P
Mod Pathol; 2023 Jun; 36(6):100166. PubMed ID: 36990279
[TBL] [Abstract] [Full Text] [Related]
6. Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome.
Parry EM; Leshchiner I; Guièze R; Johnson C; Tausch E; Parikh SA; Lemvigh C; Broséus J; Hergalant S; Messer C; Utro F; Levovitz C; Rhrissorrakrai K; Li L; Rosebrock D; Yin S; Deng S; Slowik K; Jacobs R; Huang T; Li S; Fell G; Redd R; Lin Z; Knisbacher BA; Livitz D; Schneider C; Ruthen N; Elagina L; Taylor-Weiner A; Persaud B; Martinez A; Fernandes SM; Purroy N; Anandappa AJ; Ma J; Hess J; Rassenti LZ; Kipps TJ; Jain N; Wierda W; Cymbalista F; Feugier P; Kay NE; Livak KJ; Danysh BP; Stewart C; Neuberg D; Davids MS; Brown JR; Parida L; Stilgenbauer S; Getz G; Wu CJ
Nat Med; 2023 Jan; 29(1):158-169. PubMed ID: 36624313
[TBL] [Abstract] [Full Text] [Related]
7. Genomics improves risk stratification of adults with T-cell acute lymphoblastic leukemia enrolled in measurable residual disease-oriented trials.
González-Gil C; Morgades M; Lopes T; Fuster-Tormo F; García-Chica J; Zhao R; Montesinos P; Torrent A; Diaz-Beya M; Coll R; Hermosín L; Mercadal S; González-Campos J; Zamora L; Artola T; Vall-Llovera F; Tormo M; Gil-Cortés C; Barba P; Novo A; Ribera J; Bernal T; De Ugarriza PL; Queipo MP; Martínez-Sánchez P; Giménez A; González-Martínez T; Cladera A; Cervera J; Fernández-Martín R; Ardaiz MÁ; Vidal MJ; Baena Á; López-Bigas N; Bigas A; Maciejewski J; Orfao A; Ribera JM; Genescà E
Haematologica; 2023 Apr; 108(4):969-980. PubMed ID: 36325893
[TBL] [Abstract] [Full Text] [Related]
8. TET-2 mutations predict poor outcomes and are associated with unfavorable clinical-biological features in PTCL, not otherwise specified and angioimmunoblastic T-cell lymphoma in Brazilian patients.
de Pádua Covas Lage LA; Barreto GC; Culler HF; Cavalcante JB; de Oliveira Alves LB; Nardinelli L; Bendit I; Zerbini MCN; Rocha V; Pereira J
Cancer Biomark; 2022; 35(2):179-191. PubMed ID: 36093687
[TBL] [Abstract] [Full Text] [Related]
9. Angioimmunoblastic T-Cell lymphoma with Exuberant CD30-Positive Follicular Dendritic Cell Proliferation in a SARS-CoV-2 Patient: The Role of Mutational Analysis to Exclude an Associated Follicular Dendritic Cell Sarcoma.
Rogges E; Pelliccia S; Lopez G; Barresi S; Tafuri A; Alaggio R; Di Napoli A
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012614
[TBL] [Abstract] [Full Text] [Related]
10. Primary cutaneous peripheral T-cell lymphomas with a T-follicular helper phenotype: an integrative clinical, pathological and molecular case series study.
Wang L; Rocas D; Dalle S; Sako N; Pelletier L; Martin N; Dupuy A; Tazi N; Balme B; Vergier B; Beylot-Barry M; Carlotti A; Bagot M; Battistella M; Chaby G; Ingen-Housz-Oro S; Gaulard P; Ortonne N
Br J Dermatol; 2022 Dec; 187(6):970-980. PubMed ID: 35895386
[TBL] [Abstract] [Full Text] [Related]
11. The role of clonal hematopoiesis as driver of therapy-related myeloid neoplasms after autologous stem cell transplantation.
Gramegna D; Bertoli D; Cattaneo C; Almici C; Re A; Belotti A; Borlenghi E; Lanzi G; Archetti S; Verardi R; Brugnoni D; Sciumè M; Daffini R; Roccaro AM; Tucci A; Rossi G
Ann Hematol; 2022 Jun; 101(6):1227-1237. PubMed ID: 35380239
[TBL] [Abstract] [Full Text] [Related]
12. Distinct power of bone marrow microRNA signatures and tumor suppressor genes for early detection of acute leukemia.
Memari F; Tavakolpour V; Mohajeri N; Poopak B; Fallah P; Alizadeh E; Kouhkan F; Zarghami N
Clin Transl Oncol; 2022 Jul; 24(7):1372-1380. PubMed ID: 35247197
[TBL] [Abstract] [Full Text] [Related]
13. Clonal evolution in patients developing therapy-related myeloid neoplasms following autologous stem cell transplantation.
Soerensen JF; Aggerholm A; Rosenberg CA; Bill M; Kerndrup GB; Ebbesen LH; Hansen MH; Roug AS; Ludvigsen M
Bone Marrow Transplant; 2022 Mar; 57(3):460-465. PubMed ID: 35027675
[TBL] [Abstract] [Full Text] [Related]
14. The Application of NextGen Sequencing in the diagnosis of Myeloid Neoplasms in Myeloma Patients With Cytopenia.
Song J; Zhang H; Dong N; Zhang X; Hussaini M; Jain A; Moscinski L; Shain K; Baz R; Alsina M; Nishihori T; Zhang L
Clin Lymphoma Myeloma Leuk; 2022 Jun; 22(6):e414-e426. PubMed ID: 34998786
[TBL] [Abstract] [Full Text] [Related]
15. Excellent Prognosis of Low-Risk Myelodysplastic Syndromes (MDS) Without Detectable Myeloid-Related Mutations.
Polprasert C; Niparuck P; Rattanathammethee T; Chuncharunee S; Kobbuaklee S; Songserm K; Suksusut A; Trithiphen S; Lanamtieng T; Kongkiatkamon S; Chanswangphuwana C; Lawasut P; Bunworasate U; Rojnuckarin P
Clin Lymphoma Myeloma Leuk; 2022 May; 22(5):e293-e299. PubMed ID: 34840089
[TBL] [Abstract] [Full Text] [Related]
16. Prognostic Impact of Concurrent dnmt3a, FLT3 and NPM1 Gene Mutations in Acute Myeloid Leukemia Patients.
Elrhman HAEA; El-Meligui YM; Elalawi SM
Clin Lymphoma Myeloma Leuk; 2021 Dec; 21(12):e960-e969. PubMed ID: 34376373
[TBL] [Abstract] [Full Text] [Related]
17. Genetic Heterogeneity in Chronic Myeloid Leukemia: How Clonal Hematopoiesis and Clonal Evolution May Influence Prognosis, Treatment Outcome, and Risk of Cardiovascular Events.
Sant'Antonio E; Camerini C; Rizzo V; Musolino C; Allegra A
Clin Lymphoma Myeloma Leuk; 2021 Sep; 21(9):573-579. PubMed ID: 34078586
[TBL] [Abstract] [Full Text] [Related]
18. Oncogenetic landscape and clinical impact of IDH1 and IDH2 mutations in T-ALL.
Simonin M; Schmidt A; Bontoux C; Dourthe MÉ; Lengliné E; Andrieu GP; Lhermitte L; Graux C; Grardel N; Cayuela JM; Huguet F; Arnoux I; Ducassou S; Macintyre E; Gandemer V; Dombret H; Petit A; Ifrah N; Baruchel A; Boissel N; Asnafi V
J Hematol Oncol; 2021 May; 14(1):74. PubMed ID: 33941203
[TBL] [Abstract] [Full Text] [Related]
19. 14q32 rearrangements deregulating BCL11B mark a distinct subgroup of T-lymphoid and myeloid immature acute leukemia.
Di Giacomo D; La Starza R; Gorello P; Pellanera F; Kalender Atak Z; De Keersmaecker K; Pierini V; Harrison CJ; Arniani S; Moretti M; Testoni N; De Santis G; Roti G; Matteucci C; Bassan R; Vandenberghe P; Aerts S; Cools J; Bornhauser B; Bourquin JP; Piazza R; Mecucci C
Blood; 2021 Sep; 138(9):773-784. PubMed ID: 33876209
[TBL] [Abstract] [Full Text] [Related]
20. Clinicopathological characterization of follicular helper T-cell-derived peripheral T-cell lymphoma involving Waldeyer's ring.
Wang J; Tang W; Zhang W; Wang J; Chen F; Zhong L; Chen Y; Chen G
Virchows Arch; 2021 Aug; 479(2):355-363. PubMed ID: 33650043
[TBL] [Abstract] [Full Text] [Related]
[Next]
